MASSDEVICE ON CALL —Boston Scientific Corp. (NYSE:BSX) began seeking approval for a $41 building project in Ireland to house the neurovascular unit it sold to Stryker Corp. (NYSE:SYK) earlier this year.
The 100,000 square foot facility will live on Boston Scientific’s Cork, Ireland, campus but will be operated by Stryker, and some 600 local BSX employees will transfer to the new facility when it’s ready.